. 2016 Dec 26;49(1):1–9. doi: 10.4143/crt.2016.606
Copyright © 2017 by the Korean Cancer Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig. 2.
Currently developed anticancer drugs and their targets.